List of Vascular Biogenics patents

Patents where

Current Assignee

Name

Vascular Biogenics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7585666 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy	Patent 7585666 was granted and assigned to Vascular Biogenics on September, 2009 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7585666	September 8, 2009
‌ US Patent 7504388 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis	Patent 7504388 was granted and assigned to Vascular Biogenics on March, 2009 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7504388	March 17, 2009
‌ US Patent 7579327 Promoters exhibiting endothelial cell specificity and methods of using same	Patent 7579327 was granted and assigned to Vascular Biogenics on August, 2009 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7579327	August 25, 2009
‌ US Patent 7902176 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders	Patent 7902176 was granted and assigned to Vascular Biogenics on March, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7902176	March 8, 2011
‌ US Patent 7279459 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis	Patent 7279459 was granted and assigned to Vascular Biogenics on October, 2007 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7279459	October 9, 2007
‌ US Patent 7625882 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders	Patent 7625882 was granted and assigned to Vascular Biogenics on December, 2009 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7625882	December 1, 2009
‌ US Patent 8999960 Oxidized thiophospholipid compounds and uses thereof	Patent 8999960 was granted and assigned to Vascular Biogenics on April, 2015 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8999960	April 7, 2015
‌ US Patent 7973023 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders	Patent 7973023 was granted and assigned to Vascular Biogenics on July, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7973023	July 5, 2011
‌ US Patent 9567605 Methods for use of a specific anti-angiogenic adenoviral agent	Patent 9567605 was granted and assigned to Vascular Biogenics on February, 2017 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	9567605	February 14, 2017
‌ US Patent 10464957 Oxidized lipids and methods of use thereof	Patent 10464957 was granted and assigned to Vascular Biogenics on November, 2019 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	10464957	November 5, 2019
‌ US Patent 9682154 Methods of inducing responsiveness to anti-angiogenic agent	Patent 9682154 was granted and assigned to Vascular Biogenics on June, 2017 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	9682154	June 20, 2017
‌ US Patent 10022388 Oxidized lipids and treatment or prevention of fibrosis	Patent 10022388 was granted and assigned to Vascular Biogenics on July, 2018 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	10022388	July 17, 2018
‌ US Patent 7893291 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis	Patent 7893291 was granted and assigned to Vascular Biogenics on February, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7893291	February 22, 2011
‌ US Patent 8158611 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis	Patent 8158611 was granted and assigned to Vascular Biogenics on April, 2012 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8158611	April 17, 2012
‌ US Patent 9403887 Endothelial cell-specific polynucleotides and use thereof	Patent 9403887 was granted and assigned to Vascular Biogenics on August, 2016 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	9403887	August 2, 2016
‌ US Patent 8039261 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis	Patent 8039261 was granted and assigned to Vascular Biogenics on October, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8039261	October 18, 2011
‌ US Patent 8071740 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis	Patent 8071740 was granted and assigned to Vascular Biogenics on December, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8071740	December 6, 2011
‌ US Patent 10383954 Methods of inducing responsiveness to anti-angiogenic agent	Patent 10383954 was granted and assigned to Vascular Biogenics on August, 2019 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	10383954	August 20, 2019
‌ US Patent 11191848 Methods of inducing responsiveness to anti-angiogenic agent	Patent 11191848 was granted and assigned to Vascular Biogenics on December, 2021 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	11191848	December 7, 2021
‌ US Patent 8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy	Patent 8415318 was granted and assigned to Vascular Biogenics on April, 2013 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8415318	April 9, 2013
‌ US Patent 7807847 Process for the preparation of oxidized phospholipids	Patent 7807847 was granted and assigned to Vascular Biogenics on October, 2010 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7807847	October 5, 2010
‌ US Patent 7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy	Patent 7989427 was granted and assigned to Vascular Biogenics on August, 2011 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	7989427	August 2, 2011
‌ US Patent 9006217 High-purity phospholipids	Patent 9006217 was granted and assigned to Vascular Biogenics on April, 2015 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	9006217	April 14, 2015
‌ US Patent 8916378 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy	Patent 8916378 was granted and assigned to Vascular Biogenics on December, 2014 by the United States Patent and Trademark Office.	Vascular Biogenics	Vascular Biogenics	United States Patent and Trademark Office	8916378	December 23, 2014
‌ US Patent 8124800 Process for the preparation of oxidized phospholipids	Patent 8124800 was granted and assigned to Vascular Biogenics on February, 2012 by the United States Patent and Trademark Office.		Vascular Biogenics	United States Patent and Trademark Office	8124800	February 28, 2012

Results per page:

43 results

0 selected

43 results

0 selected